A common mutation in methylenetetrahydrofolate reductase gene among the Japanese population

Japanese Journal of Human Genetics

Volumn 41, Issue 2, 1996, Pages 247-251

  Nishio, Hisahide ^a,d   Lee, Myeong Jin ^a   Fujil, Motoko ^a   Kario, Kazuomi ^b   Kayaba, Kazunori ^a   Shimada, Kazuyuki ^c   Matsuo, Masafumi ^b   Sumino, Kimiaki ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Awaji Hokudan Public Clinic   (Japan)

^c Department of Community and Family Medicine ^*

^d JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

5,10 methylenetetrahydrofolate reductase; hyperhomocysteinemia; hypertension; transition mutation

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE;

EID: 0030035780     PISSN: 09168478     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01875985     Document Type: Article

References (10)

1. Boers GH, Smals AG, Trijbels FJ, Fowler B, Bakkeren JA, Schoonderwaldt HC, Kleijer WJ, Kloppenborg PW (1985): Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 313: 709-715
2. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I (1991): Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324: 11491155
3. Engbersen AM, Franken DG, Boers GH, Stevens EM, Trijbels FJ, Blom HJ (1995): Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 56: 142-150
4. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R (1995): A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113
5. Goyette P, Frosst P, Rosenblatt DS, Rozen R (1995): Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet 56: 1052-1059
6. Haffner SM, Ferrannini E, Hazuda HP, Stern MP ( 1992): Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension 20: 38-45
7. Kang SS, Wong PW, Bock HG, Horwitz A, Grix A (199la): Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations. Am J Hum Genet 48: 546-551
8. Kang SS. Wong PW, Bock HG, Horwitz A, Grix A (1991b): Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 48: 536-545
9. Kluijtmans LAJ, van der Heuvel LPWJ, Boers GHJ, Frosst P, Stevens EMB, van Oost BA. den Heijer M, Trijbels FJM, Rozen R, Blom HJ (1996): Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 58: 35-41
10. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, O'Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH (1995): Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 332: 286-291